| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/11/2006 | WO2004096151A3 Methods and devices for the sustained release of multiple drugs |
| 05/11/2006 | WO2004056323A3 Method of treating angiogenic tissue growth |
| 05/11/2006 | US20060100609 Generic multi-step therapeutic treatment protocol |
| 05/11/2006 | US20060100608 Controlled release device and method using electrothermal ablation |
| 05/11/2006 | US20060100584 Flexible transdermal drug delivery device for uniform penetration of chemodenervating botulinum toxins |
| 05/11/2006 | US20060100479 Implantable medical device for controlled release of substance |
| 05/11/2006 | US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100370 Random and non-random alkylene oxide polymer alloy compositions |
| 05/11/2006 | US20060100369 Bifunctional-modified hydrogels |
| 05/11/2006 | US20060100353 Coating compositions for basecoats containing acrylic branched polymers |
| 05/11/2006 | US20060100352 Vinyl amide-containing adhesive compositions for plastic bonding, and methods and products utilizing same |
| 05/11/2006 | US20060100351 Rapid drying lacquers containing impoved rheology control additive |
| 05/11/2006 | US20060100350 Rapid drying lacquers containing graft copolymers with segmented arms |
| 05/11/2006 | US20060100276 Method of treating neutrophil-related diseases with topical anesthetics |
| 05/11/2006 | US20060100271 Stabilized aqueous ranitidine compositions |
| 05/11/2006 | US20060100268 Method of treating atherosclerosis or restenosis using microtube stabilizing agent |
| 05/11/2006 | US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100214 Fast dissolving and taste masked oral dosage form comprising sildenafil |
| 05/11/2006 | US20060100182 Pharmaceutical compositions for the treatment of urinary incontinence |
| 05/11/2006 | US20060100165 aqueous emulsion for the treatment of rosacea skin disorders, acne, dermatitis; Glycerol, Isopropyl palmitate, Cetyl alcohol, Stearyl monostearate, Oleyl alcohol, Ceteareth-20; good cosmetic properties and long shelf-life with minimum of 2 years |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060099350 Method and apparatus for applying powder in a pattern to a substrate |
| 05/11/2006 | US20060099324 Composition comprising viscous fibers and viscosity-lowering proteins |
| 05/11/2006 | US20060099278 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099271 Contacting microparticles og biodegradable, biocompatible polymer matrix comprising a peptide with halogenated solvent with nonaqueous washing system |
| 05/11/2006 | US20060099270 Production of small particles |
| 05/11/2006 | US20060099269 Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
| 05/11/2006 | US20060099268 Photochemically crosslinked collagen scaffolds and methods for their preparation |
| 05/11/2006 | US20060099267 High-dosage extended-release formulation of gepirone |
| 05/11/2006 | US20060099266 Slow release formulation of clarithromycin |
| 05/11/2006 | US20060099265 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 05/11/2006 | US20060099264 biodegradable; biocompatible; colloids |
| 05/11/2006 | US20060099263 Antidepressant dosage form |
| 05/11/2006 | US20060099262 Methods and formulations for making controlled release oral dosage form |
| 05/11/2006 | US20060099261 Methods and formulations for making controlled release oral dosage form |
| 05/11/2006 | US20060099260 Methods and formulations for making pharmaceutical compositions containing bupropion |
| 05/11/2006 | US20060099259 Propranolol formulations |
| 05/11/2006 | US20060099258 Propranolol formulations |
| 05/11/2006 | US20060099257 Controlled drug delivery systems providing variable release rates |
| 05/11/2006 | US20060099256 Microspheres and related processes and pharmaceutical compositions |
| 05/11/2006 | US20060099255 solid dosage forms for oral administration, reducing the range in daily dosages required to control pain in human patients |
| 05/11/2006 | US20060099254 Sustained release drug delivery system and method |
| 05/11/2006 | US20060099253 Antibiotic product formulation |
| 05/11/2006 | US20060099252 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 05/11/2006 | US20060099251 Formulations of finasteride |
| 05/11/2006 | US20060099250 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets |
| 05/11/2006 | US20060099249 Modified release formulations of at least one form of tramadol |
| 05/11/2006 | US20060099248 5,6,7-Trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 05/11/2006 | US20060099247 Liquid, gas and/or vapor phase delivery systems |
| 05/11/2006 | US20060099246 Non-gelatin soft capsule system |
| 05/11/2006 | US20060099245 Hydrodynamically balancing oral drug delivery system with biphasic release |
| 05/11/2006 | US20060099244 Liposomal formulation for oral administration of glutathione (reduced) |
| 05/11/2006 | US20060099243 Oral administering; oral delivering active materials to gastrointestinal system; tablet with enteric coating |
| 05/11/2006 | US20060099242 drug delivery devices comprising backings and pressure sensitive adhesives comprising copolymers containing drugs |
| 05/11/2006 | US20060099240 eating candy comprising homogeneous mixtures of guaran and derivatives, hydroxycitric acid, tyrosine, Vitamin B6, Vitamin B12, cyanocobalamin, corn syrup and maltodextrin and derivatives, as anorexigenic agents |
| 05/11/2006 | US20060099239 Dietary supplement for promoting removal of heavy metals from the body |
| 05/11/2006 | US20060099230 Novel formulations of eprosartan with enhanced bioavailability |
| 05/11/2006 | US20060099227 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyethyl Starch |
| 05/11/2006 | US20060099197 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/11/2006 | US20060099182 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 05/11/2006 | US20060099179 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 05/11/2006 | US20060099173 Topical skin care composition |
| 05/11/2006 | US20060099166 Honey-based skin care preparation |
| 05/11/2006 | US20060099157 Ether alcohols used as solvents and emulsifiers and dispersions containing said ether alcohols |
| 05/11/2006 | US20060099151 Stable foam cream |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | US20060099149 Metered dose inhaler product |
| 05/11/2006 | US20060099148 Methods and compositions for imaging |
| 05/11/2006 | US20060099146 NIR-sensitive nanoparticle |
| 05/11/2006 | US20060099141 Radiation sensitive liposomes |
| 05/11/2006 | US20060096715 Method for preparing microsphere |
| 05/11/2006 | US20060096594 Actuation indicator for a dispensing device |
| 05/11/2006 | US20060096522 Apparatus and process for preparing crystalline particles |
| 05/11/2006 | US20060096500 Microcrystalline cewllulose compositions |
| 05/11/2006 | US20060096252 Process for producing aspheric seamless capsule and apparatus therefor |
| 05/11/2006 | DE3943807B4 Prepn. for iron supply - comprises specified amts. of specified iron contg. cpd., sodium carbonate or bi:carbonate and a neutralising agent |
| 05/11/2006 | DE19715477B4 Verfahren und Vorrichtung zur Herstellung hartmagnetischer Einbereichsteilchen mit hoher Koerzitivfeldstärke Method and apparatus for the production of hard magnetic single-domain particles with high coercivity |
| 05/11/2006 | DE10356925B4 Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung An inhaler for basic pharmaceutical agents, and methods for its preparation |
| 05/11/2006 | DE102005002469B3 Encapsulation of substances in liposome comprises applying two different monolayers on porous carrier membrane; applying different fluid volumes on monolayers; bringing compressible membrane and lacing the dismantled area to liposome |
| 05/11/2006 | DE102004054730A1 Serumstabile amphotere Liposomen Serum-stable amphoteric liposomes |
| 05/11/2006 | DE10055742B4 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/11/2006 | CA2762076A1 Aliphatic amine polymer salts for tableting |
| 05/11/2006 | CA2586619A1 Bacteriophage compositions |
| 05/11/2006 | CA2586611A1 Encapsulated bacteriophage formulation |
| 05/11/2006 | CA2586547A1 Stabilized individually coated ramipril particles, compositions and methods |
| 05/11/2006 | CA2586035A1 Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use |
| 05/11/2006 | CA2585972A1 Manufacturing process for liposomal preparations |
| 05/11/2006 | CA2585855A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 05/11/2006 | CA2585852A1 Dye-free pharmaceutical suspensions and related methods |
| 05/11/2006 | CA2585841A1 Method of reducing nosocomial infections |
| 05/11/2006 | CA2585754A1 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy |
| 05/11/2006 | CA2585471A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 05/11/2006 | CA2585301A1 Immediate release film coating |
| 05/11/2006 | CA2585095A1 Oral solid dosage forms containing a low dose of estradiol |
| 05/11/2006 | CA2584980A1 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 05/11/2006 | CA2584684A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 05/11/2006 | CA2584583A1 Lyophilized liposome formulations and method |